Wealthspring Capital’s Isleworth Healthcare Acquisition Corporation Common stock ISLE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-542,408
Closed -$5.4M 513
2022
Q2
$5.4M Sell
542,408
-73,012
-12% -$724K 1.01% 8
2022
Q1
$6.09M Sell
615,420
-10,585
-2% -$104K 1.19% 7
2021
Q4
$6.16M Sell
626,005
-38,195
-6% -$376K 1.32% 5
2021
Q3
$6.53M Sell
664,200
-50,527
-7% -$493K 1.57% 6
2021
Q2
$7M Sell
714,727
-42,368
-6% -$414K 1.76% 7
2021
Q1
$7.34M Buy
+757,095
New +$7.32M 1.99% 7

Wealthspring Capital's ISLE Position: Q3 2022 in Review

Wealthspring Capital sold out of Isleworth Healthcare Acquisition Corporation Common stock (ISLE) in Q3 2022, closing a stake of 542,408 shares — an estimated $5.4M sold.

Wealthspring Capital first reported a position in ISLE in Q1 2021 and held it in 6 quarters. The position peaked at $7.34M in Q1 2021. 0 funds tracked by Wall St. Rank hold ISLE as of Q3 2022.

  • Wealthspring Capital reported no remaining Isleworth Healthcare Acquisition Corporation Common stock position as of Q3 2022 after selling out during the quarter.
  • Wealthspring Capital sold 542,408 Isleworth Healthcare Acquisition Corporation Common stock shares in Q3 2022, an estimated $5.4M.
  • Wealthspring Capital first reported a position in Isleworth Healthcare Acquisition Corporation Common stock in Q1 2021 and held it in 6 quarters.
  • Wealthspring Capital's Isleworth Healthcare Acquisition Corporation Common stock position peaked at $7.34M in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Isleworth Healthcare Acquisition Corporation Common stock as of Q3 2022.

Based on Wealthspring Capital's 13F filing for Q3 2022, filed 27 Oct 2022.